MARKET

XBI

XBI

SPDR® S&P Biotech ETF
NYSEARCA
89.06
-0.64
-0.71%
Opening 11:38 02/07 EST
OPEN
89.86
PREV CLOSE
89.70
HIGH
89.99
LOW
88.79
VOLUME
2.31M
TURNOVER
98.87M
52 WEEK HIGH
99.16
52 WEEK LOW
61.78
TOTAL ASSET
8.67B
YTD YIELD
-1.26%
1D
5D
1M
3M
1Y
5Y
Verona Pharma: Small Biotech Targeting $10Bn COPD Market With A Late Stage Drug
Seeking Alpha · 8h ago
UBS: Inflection point coming for the market...but it's not here yet
Seeking Alpha · 1d ago
The Week On Wall Street - Party Now, Reality Later
Seeking Alpha · 3d ago
KemPharm: Now A Rare Disease Play, Upgrading To A Buy Rating
Seeking Alpha · 4d ago
Lessons Of SPXS Decay
Seeking Alpha · 5d ago
MorphoSys: Negative Enterprise Value Biotech, But Lack Of Near-Term Catalyst
Seeking Alpha · 6d ago
LABU: Leveraged Biotech ETF Review
Seeking Alpha · 6d ago
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
Benzinga · 01/31 12:55
More
Profile
Fund Name
SPDR® S&P Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P Biotechnology Select Industry TR USD
Advisor Company
SSgA Funds Management Inc
Custodian
State Street Bank and Trust Company
Manager
Michael Feehily, Raymond Donofrio, Karl Schneider